ãã€ãªå»è¬åäŒæ¥ã§ãã FibroGen, Inc. ã¯ãæ·±å»ãªæªå
è¶³å»çããŒãºãæ²»çããããã®æ²»çè¬ãçºèŠãéçºãåååããŠããŸããå瀟ã¯ãç±³åœãšãšãŒãããã§æ
¢æ§è
èç
ã«äŒŽãè²§è¡ã®æ²»çè¬ãšããŠç¬¬ III çžèšåºéçºæ®µéã«ããäœé
žçŽ èªå°å åãããªã³æ°Žé
žåé
µçŽ ã®çµå£å°ååé»å®³å€ Roxadustat ãéçºããŠãããäžåœã§ã¯éªšé«ç°åœ¢æçå矀ã«äŒŽãè²§è¡ã®æ²»çè¬ãšããŠç¬¬ II/III çžéçºæ®µéã«ãããŸãããŸããå瀟ã¯çµåçµç¹æé·å åã®æŽ»æ§ãé»å®³ããããã¢ãã¯ããŒãã«æäœ Pamrevlumab ãéçºããŠãããç¹çºæ§èºç·ç¶çãèµèçãèç·ç¶çãç³å°¿ç
æ§è
èç
ã®æ²»çè¬ãšããŠç¬¬ III çžèšåºéçºæ®µéã«ããããã¥ã·ã§ã³ãåçãžã¹ãããã£ãŒã®æ²»çè¬ãšããŠç¬¬ II çžè©Šéšãè¡ãããŠããŸããå瀟㯠Astellas Pharma Inc. ããã³ AstraZeneca AB ãšææºå¥çŽãçµãã§ããŸãã FibroGen, Inc. 㯠1993 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã